LY 56110

structure given in first source

Also Known As:

5-(bis(4-chlorophenyl)methyl)pyrimidine; LY-56110; LY56110

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Flushing 01/01/1991 - "In vitro, 4-OHA and LY56110 had 50% inhibitory concentrations of 0.1 microM and 13 nM. Treatment of gilts with 4-OHA reduced total estrogens in uterine flushings by 57% (P less than .02), whereas treatment with LY56110 did not significantly lower total estrogen content in uterine flushings. "